Your browser doesn't support javascript.
loading
Effect of baseline characteristics on the efficacy of dulaglutide added to basal insulin in Chinese patients with type 2 diabetes: A subgroup analysis of AWARD-CHN3.
Tong, Guoyu; Lu, Song; Kuang, Hongyu; Li, Yan; Deng, Yuying; Lou, Ying; Wang, Weimin; Zhu, Dalong.
Affiliation
  • Tong G; Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, China.
  • Lu S; Chongqing General Hospital, Chongqing, China.
  • Kuang H; Department of Endocrinology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Li Y; Department of Endocrinology and Metabolism, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Deng Y; Lilly China Drug Development and Medical Affairs Center, Eli Lilly (Suzhou) Pharmaceutical Co., Ltd., Shanghai, China.
  • Lou Y; Lilly China Drug Development and Medical Affairs Center, Eli Lilly (Suzhou) Pharmaceutical Co., Ltd., Shanghai, China.
  • Wang W; Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, China.
  • Zhu D; Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, China.
Diabetes Obes Metab ; 26(4): 1540-1543, 2024 Apr.
Article in En | MEDLINE | ID: mdl-38185739
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Glucagon-Like Peptides Limits: Humans Country/Region as subject: Asia Language: En Journal: Diabetes Obes Metab Year: 2024 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Glucagon-Like Peptides Limits: Humans Country/Region as subject: Asia Language: En Journal: Diabetes Obes Metab Year: 2024 Document type: Article